Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01666717

Enrollment

204

Registered

2012-08-16

Start date

2008-08-31

Completion date

2012-05-31

Last updated

2012-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Brief summary

The purpose of the study is to evaluate fecal metabolites profiles of Inflammatory Bowel Disease(IBD) patients versus healthy controls (HC).

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Clinical diagnosis of IBD * Age \>18 years

Exclusion criteria

* Use of antibiotics in the preceding month * Intake of pre- or probiotics

Countries

Belgium

Outcome results